Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.
Year | ID | Type | Category | Title | Authors |
---|
2016 | RH40 | Poster | Rehabilitation Research and Strategies |
Effect of Fatigue on Sensory Impairment in Multiple Sclerosis |
Stefanie DiCarrado, DPT, PT, CPT, CES, PES, Herbert I Karpatkin, PT, DSc, NCS, MSCS, Julia Karsten, SPT, Ashley McLoughlin, SPT, Melanie Rocchio, SPT and Christina Bianchi, SPT, Physical Therapy, Hunter College, New York, NY |
2016 | RH41 | Poster | Rehabilitation Research and Strategies |
Oxygen Uptake Efficiency Slope Across the Disability Spectrum in Persons with Multiple Sclerosis |
Thomas A Edwards, BKin1, Rachel E Klaren, BS1, Robert W Motl, PhD1 and Lara A Pilutti, PhD2, (1)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, (2)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL |
2016 | RH42 | Poster | Rehabilitation Research and Strategies |
Mscares: Therapy Protocol for Persons with Multiple Sclerosis |
Tracy Flemming Tracy, OTR/L, MSCS, MSSMC1, Emily S Riser, MD2 and Danielle Lehman, OTS1, (1)Rehabilitation, Tanner Center for MS, Birmingham, AL, (2)Tanner Center for MS, Birmingham, AL |
2016 | RH43 | Poster | Rehabilitation Research and Strategies |
Comparison of Actigraph, Fitbit and Manual Step Count during a Two-Minute Walk Test in People with Multiple Sclerosis: A Pilot Study |
Valerie A J Block, PT DPTSc(c)1,2, Antoine Lizée, MSc1, Elizabeth Crabtree-Hartman, MD, MAS1, Carolyn J Bevan, MD1, Jennifer Graves, MD, PhD3, Ari J Green, MD4, Bardia Nourbakhsh, MD1, Matthew Tremblay, MD, PhD1, Gregory M Marcus, MD, MAS, FACC, FAHA, FHRS5, Jeffrey E Olgin, MD6, Mark Pletcher, MD, MPH7, Bruce AC Cree, MD, PhD8, Diane D Allen, PT, PhD9 and Jeffrey M Gelfand, MD, MAS1, (1)UCSF, San Francisco, CA, (2)Physical Therapy, San Francisco State University, San Francisco, CA, (3)UCSF Pediatric MS Center, San Francisco, CA, (4)Neurology, University of California, San Francisco, San Francisco, CA, (5)Director of Clinical Research, Division of Cardiology, UCSF, San Francisco, CA, (6)505 Parnassus Avenue Room M-1182A,, UCSF, San Francisco, CA, (7)University of California San Francisco Medical Center, San Francisco, CA, (8)University of California San Francisco, San Francisco, CA, (9)Graduate Program in Physical Therapy, University of California San Francisco/San Francisco State University, San Francisco, CA |
2016 | RH44 | Poster | Rehabilitation Research and Strategies |
Physiotherapy and Walking Outcomes in Adults with Multiple Sclerosis: A Meta-Analysis |
Yvonne C Learmonth, PhD, Ipek Ensari, EdM and Robert W Motl, PhD, Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL |
2016 | SC01 | Poster | Basic Science |
Blocking the Lipid Metabolism As a New Treatment Strategy for Multiple Sclerosis |
Anne S. Mørkholt, PhD Student1, Soeren Nielsen, MD. Prof.2 and John D Nieland, PhD. Assoc. Prof.1, (1)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark, (2)Health Science and Technology, Aalborg University, Aalborg, Denmark |
2016 | SC02 | Poster | Basic Science |
Effects of Disability on Lower Extremity Joint Contributions and Total Support Moment in Individuals with Multiple Sclerosis |
Brandi Decoux, M.S.1, Lauren Brewer, M.Ed.1, Emily Riser, MD2 and Wei Liu, Ph.D.1, (1)School of Kinesiology, Auburn University, Auburn, AL, (2)Tanner Center and Foundation for Multiple Sclerosis, Birmingham, AL |
2016 | SC03 | Poster | Basic Science |
T- and B-Lymphocyte Modulation Associated with Teriflunomide Treatment in Patients with Relapsing-Remitting MS: Analysis of the Phase 3b TERI-DYNAMIC Study |
Heinz Wiendl, MD1, Catharina C Gross, PhD1, Maren Lindner, PhD1, Melanie Eschborn, MSc1, Linda Weisser, PhD1, Anita Posevitz-Fejfar, PhD1, Andreas Schulte-Mecklenbeck, PhD1, Bart Van Wijmeersch, MD, PhD2, Sandrine Brette, MSc3, Timothy J Turner, PhD4, Alexandre Jagerschmidt, PhD5, Amit Bar-Or, MD, FRCPC6, Raymond Hupperts, MD, PhD7 and Luisa Klotz, MD1, (1)University of Münster, Münster, Germany, (2)Hasselt University, Campus Diepenbeek, Hasselt, Belgium, (3)Lincoln, Boulogne-Billancourt, France, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Sanofi R&D, Chilly-Mazarin, France, (6)Montreal Neurological Institute, Montreal, QC, Canada, (7)School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands |
2016 | SC04 | Poster | Basic Science |
Modeling Neural Progenitor Cell Dysfunction and Neurogenesis in a Stem Cell-Based Assay Model of Multiple Sclerosis |
Jaime Imitola, MD, Laboratory for Neural Stem Cells and Functional Neurogenetics, Department of Neurology, Ohio State University, Columbus, OH, Michael K Racke, MD, The Ohio State University Wexner Medical Center, Columbus, OH and Fumihiro Watanabe, MD PhD, Ohio State University, Columbus, OH |
2016 | SC05 | Poster | Basic Science |
Microbial Sequences in Multiple Sclerosis Brain Specimens |
John D Kriesel, MD1, Preetida J Bhetariya, Ph.D.2, Cheryl Palmer, MD3, Kael F Fischer, Ph.D.3 and Alun Thomas, Ph.D.4, (1)Internal Medicine/Infectious Disease, University of Utah School of Medicine, Salt Lake City, UT, (2)Internal Medicine/Infectious Disease, University of Utah, Salt Lake City, UT, (3)Pathology, University of Utah School of Medicine, Salt Lake City, UT, (4)Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT |
2016 | SC06 | Poster | Basic Science |
Dimethyl Fumarate Associated Lymphopenia Appears Driven by Selective CD8+ T Cell Depletion |
Jong-Mi Lee, MSN – NP, Neuroscience, Stanford Healthcare, Stanford, CA and Jeffrey Dunn, MD, Neurology & Neurological Sciences, Stanford University Medical Center, Stanford, CA |
2016 | SC07 | Poster | Basic Science |
Novel Biomarker of Balance Impairment in Minimally Impaired Individuals with MS |
Kathleen L Roeing, BS, Douglas A Wajda, MS and Jacob J Sosnoff, PhD, Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL |
2016 | SC08 | Poster | Basic Science |
Assessing the Role of Citrullination and Lipid Interaction with Myelin Basic Protein in Multiple Sclerosis Etiology |
Kenneth Kastaniegaard, MS1, Tue B Bennike, PhD1, Soeren Nielsen, MD. Prof.2, Allan Stensballe, PhD. Assoc. Prof.3 and John D Nieland, PhD. Assoc. Prof.3, (1)Department of Health Science and Technology, Aalborg University, Aalborg, Denmark, (2)Health Science and Technology, Aalborg University, Aalborg, Denmark, (3)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark |
2016 | SC09 | Poster | Basic Science |
Changes in JC (John Cunningham) Virus Antibody Index in JC Positive Multiple Sclerosis (MS) Patients Treated with Natalizumab |
Malcolm H Gottesman, MD1, Britany Klenofsky, MD2, Stephen Newman, MD3, Misu Paul, MD1, Rose Calixite, PhD1, Tiffany M Harding, CCRC, MSCS3 and Denise Grueneberg, RN1, (1)Neuroscience, Winthrop University Hosptial, Mineola, NY, (2)Medicine, Mt. Sinai Beth Isreal, NY, NY, (3)Island Neurological Associates, Plainview, NY |
2016 | SC10 | Poster | Basic Science |
Effect of ACTH1-39 on the Oligodendroglial Differentiation Pathway with Regards to Myelin Membrane Sheet Formation |
Andrew Kuo, M.S.E., Robert P. Lisak, M.D., Liljana Nedelkoska, B.S., Beverly Bealmear, B.A. and Joyce A Benjamins, Ph.D., Neurology, Wayne State University School of Medicine, Detroit, MI |
2016 | SC11 | Poster | Basic Science |
Development of Neuromyelitis Optica Spectrum Disorder with Tumefactive Demyelination after Treatment with Monoclonal Anti-Tumor Necrosis Factor Alpha Antibodies |
Thomas Shoemaker, MD, Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA |
2016 | SX01 | Poster | Symptom Management |
Dutch Guideline Adherence First-Line Injection Therapy Multiple Sclerosis |
Astrid Slettenaar, MANP1, Monique Booy, MANP2, Lisette Trommelen, MANP3, Tiny Kempkens, MANP4, Kitty Harrison, MANP5, Klaas Arts, MD, neurologist6, Annette Baars, Master neurorevalidatie en innovatie7 and Leo Visser, Professor, PhD, MD, neurologist3, (1)MS-center Twente, Enschede, Netherlands, (2)Amphia Hospital, MS centre, BREDA, Netherlands, (3)MS-center Midden Brabant, Tilburg, Netherlands, (4)Zuyderland ziekenhuis, Sittard-Geleen, Netherlands, (5)Tergooi Ziekenhuis, Blaricum, Netherlands, (6)Winkler clinic, Pro Persona, Wolfheze, Netherlands, (7)Rijnstate ziekenhuis, Arnhem, Netherlands |
2016 | SX02 | Poster | Symptom Management |
A Multicenter Randomized Controlled Trial Comparing Immediate and 6-Month Follow-up Effects of Two Group Programs on Fatigue and Self-Efficacy in People with MS |
Cinda L Hugos, MS, PT1, Yiyi Chen, PhD2, Zunqiu Chen, MS2, Aaron P Turner, Ph.D. ABPP (RP)3, Jodie K Haselkorn, MD, MPH3, Toni Chiara, PhD, PT4, Sean McCoy, PhD4, Christopher Bever Jr., MD, MBA, FAAN5 and Dennis Bourdette, MD1,2, (1)VA Portland Health Care System, Portland, OR, (2)Oregon Health & Science University, Portland, OR, (3)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (4)Malcom Randall VA Medical Center, Gainesville, FL, (5)VA Maryland Healthcare System, Baltimore, MD |
2016 | SX03 | Poster | Symptom Management |
The Meaning of Physical Activity, Exercise and Sedentary Behavior in Persons with Multiple Sclerosis |
Dominique L Kinnett-Hopkins, BS1, Robert W Motl, PhD2, Elizabeth A Hubbard, MSc2, Edward McAuley, PhD1, Lara A Pilutti, PhD2 and Yvonne C Learmonth, PhD2, (1)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, (2)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL |
2016 | SX04 | Poster | Symptom Management |
APS Therapy for Pain in People with MS: Report on a Two Year Pilot Study |
Emma s Matthews, RN BSc Hons, MS CNS – Neurology, Northampton General Hospital, Northampton, United Kingdom of Great Britain and Northern Ireland and Miranda Olding, RGN MSCN, MS CNS, Beds & Northants MS Therapy Centre, Bedford, United Kingdom of Great Britain and Northern Ireland |
2016 | SX05 | Poster | Symptom Management |
Clinical Efficacy of High Dose Biotin in the Treatment of Multiple Sclerosis |
Mariah R. Francis, Registered Nurse, MSCN, Northwest Neurology, Lake Barrington, IL |
2016 | SX06 | Poster | Symptom Management |
Real-World Comparison of Adherence and Persistence Among African-Americans with Multiple Sclerosis Treated with Fingolimod Versus Glatiramer Acetate |
Mitzi J. Williams, MD1, Yujin Park, PharmD2, Kristen Johnson, PhD, MPH3, Rachel Halpern, PhD, MPH4, Helen Trenz, MA4, Stephanie Korrer, MPH4 and Vivian Herrera, DDS, MIA, MPH3, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)University of Maryland School of Pharmacy, Baltimore, MD, (3)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Health Economics and Outcomes Research, Optum, Eden Prairie, MN |
2016 | SX07 | Poster | Symptom Management |
Real-World Comparison of Adherence and Persistence Between Hispanic Patients with Multiple Sclerosis Initiating Fingolimod or Glatiramer Acetate |
Mitzi J. Williams, MD1, Yujin Park, PharmD2, Kristen Johnson, PhD, MPH3, Rachel Halpern, PhD, MPH4, Helen Trenz, MA4, Stephanie Korrer, MPH4 and Vivian Herrera, DDS, MIA, MPH3, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)University of Maryland School of Pharmacy, Baltimore, MD, (3)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Health Economics and Outcomes Research, Optum, Eden Prairie, MN |
2016 | SX08 | Poster | Symptom Management |
Evaluation and Management of Functional Neurological Symptoms in Patients with Multiple Sclerosis |
Naema Qureshi, MD and Laura T. Safar, MD, Psychiatry, Brigham and Women’s Hospital, Boston, MA |
2016 | SX09 | Poster | Symptom Management |
Monitoring Fatigue with Mobile Phone Application- a Feasibility Study |
Pamela K Newland, RN, PhD, CMSRN, Nursing, Barnes Jewish College, Goldfarb School of Nursing, St Louis, MO |
2016 | SX10 | Poster | Symptom Management |
Using the Flinders Program to Develop a Self-Management Program for Patients with Fatigue |
Rebecca M. Floyd, Ph.D. and Lara Stepleman, Ph.D., Georgia Regents University, Augusta, GA |
2016 | SX11 | Poster | Symptom Management |
Relapse Management in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from a Real-World Analysis of Treatment Patterns |
Robert J Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, David Templeton, MBA, Medical Data Analytics, Parsippany, NJ, Beth Lesher, PharmD, BCPS, Pharmerit International, Bethesda, MD and Manoj Malhotra, MD, Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Hayward, CA |
2016 | SX12 | Poster | Symptom Management |
Low Risk of New Flu-like Symptoms in Patients Transitioning from Non-Pegylated to Pegylated Interferon Beta-1a and Mitigation with Scheduled Naproxen |
Robert T Naismith, MD1, Barry Hendin, M.D.2, Sibyl Wray, MD3, DeRen Huang, MD, PhD4, Phil You, PhD5 and Brian Werneburg, PhD5, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Phoenix Neurological Associates, Phoenix, AZ, (3)Hope Neurology Multiple Sclerosis Center, Knoxville, TN, (4)Neurology and Neuroscience Associates, Akron, OH, (5)Biogen, Cambridge, MA |
2016 | SX13 | Poster | Symptom Management |
Controversies in MS: Educational Intervention Improves Understanding of Key Concepts |
Thomas Finnegan, PhD and John Maeglin, BA, Medscape LLC, New York, NY |
2016 | TC01 | Poster | Technology Advances |
Initial Clinical Implementation of the Multiple Sclerosis Performance Test |
Claire Hara-Cleaver, CNP, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH |
2016 | TC02 | Poster | Technology Advances |
Betaconnectâ„¢ Autoinjector Comparator Market Research Study |
Donald A Barone, D.O.1, Barry A Singer, MD2, Lubo Merkov, PhD3, Mark Rametta, D.O., FACOI, FACP4 and Gustavo Suarez, MD3, (1)University of Medicine and Dentistry of NJ School of Osteopathic Medicine, Stratford, NJ, (2)Missouri Baptist Medical Center, St. Louis, MO, (3)Bayer HealthCare Pharmaceuticals, Whippany, NJ, (4)US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals, Whippany, NJ |
2016 | TC03 | Poster | Technology Advances |
Project MS E.C.H.O – Outcomes of an Innovative Pilot to Improve Access to Care in Underserved Areas |
Gary A Stobbe, MD1, Kevin N Alschuler, PhD2, Deborah P Hertz, MPH3, Annette Wundes, MD1, Gloria von Geldern, MD1, John D Scott, MD, MSc, FIDSA4, Kenton T Unruh, PhD4, Rosalind C Kalb, PhD3, Piper Reynolds, BA3, George H Kraft, MD2, Katharine Alexander, BA2 and Kurt Johnson, PhD2, (1)Neurology, University of Washington, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)National Multiple Sclerosis Society, New York, NY, (4)Dept. of Medicine, University of Washington, Seattle, WA |
2016 | TC04 | Poster | Technology Advances |
Connecting Healthcare Providers with Patients through Mobile Technology: Formula for Shared Decision Making and Improved Patient Outcomes |
Elaine Rudell, CHCP1, Patty Peterson, CHCP1, Sandeep Pulim, MD1 and James D Bowen, MD2, (1)@Point of Care, Livingston, NJ, (2)Swedish Medical Center, Seattle, WA |
2016 | TC05 | Poster | Technology Advances |
Accuracy and Precision of Smartphone Applications and Commercially Available Motion Sensors for Measuring Steps in Multiple Sclerosis |
Julia M Balto, BSc1, Dominique L Kinnett-Hopkins, BS2 and Robert W Motl, PhD2, (1)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, (2)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL |
2016 | TC06 | Poster | Technology Advances |
Reducing Disparities in MS Care: An International Videoconference-Based Provider Education and Case Consultation Program |
Kevin N Alschuler, PhD1,2, Annette Wundes, MD3, Dennis Dietrich, MD4, Bojan Boskovski, MD5, Igor Kuzmanovski, MD5, Gloria von Geldern, MD6, Katharine Alexander, BA2 and Gary Stobbe, MD6, (1)Neurology, University of Washington School of Medicine, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)Rehabilitation Medicine, University of Washington, Seattle, WA, (4)Advanced Neurology Specialists, Great Falls, MT, (5)University Clinic for Neurology, Skopje, Macedonia, The former Yugoslav Republic of, (6)Neurology, University of Washington, Seattle, WA |
2016 | TC07 | Poster | Technology Advances |
Development of a Smartphone Application for Children and Adolescents with Multiple Sclerosis and Their Parents |
Lisa V Duffy, PhD, RN, Child Neurology, Boston Children’s Hospital, Boston, MA |
2016 | TC08 | Poster | Technology Advances |
Impact of the Betaconnect Auto-Injector on Betaseron Therapy Adherence and Patient Satisfaction |
Rebecca Germino, MA, US Health Economics and Outcomes Research, Bayer Healthcare Pharmaceuticals, Whippany, NJ and Mark Rametta, D.O., FACOI, FACP, US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals, Whippany, NJ |
2016 | TC09 | Poster | Technology Advances |
Creating a Closed-Chain Biomechanical Orthotic Environment for a 52 Year Old Female to Compete in a Para-Triathlon Using the Latest Carbon Composite Technology |
Vincent DeCataldo, BOCPO, NJ LPO, Prosthetic and Orthotic, Allard USA, Rockaway, NJ |
2016 | TC10 | Poster | Technology Advances |
Semi-Automated Optical Coherence Tomography in Clinical Practice |
Zach Goodman, Undergraduate Student1, Samantha Lancia, MS1, Gautam Adusumilli, Undergraduate Student1, Courtney Dula, MS1, Paul Kealey, BS/BA2 and Robert T Naismith, MD1, (1)Department of Neurology, Division of Neuroimmunology, Washington University School of Medicine in St. Louis, St. Louis, MO, (2)Optovue, Incorporated, Freemont, CA |
CMSC Scholar © 2024 All rights Reserved | Proudly Created by Adapting Social